Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xavier de Lamballerie and Antoine Nougairède.
Xavier de Lamballerie
Connection Strength
0.823
Antoine Nougairède
  1. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res. 2021 09; 193:105137.
    View in: PubMed
    Score: 0.239
  2. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium. mBio. 2021 08 31; 12(4):e0085021.
    View in: PubMed
    Score: 0.239
  3. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021 03 19; 12(1):1735.
    View in: PubMed
    Score: 0.234
  4. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020 08 04; 10(1):13093.
    View in: PubMed
    Score: 0.056
  5. Development and Evaluation of a duo SARS-CoV-2 RT-qPCR Assay Combining Two Assays Approved by the World Health Organization Targeting the Envelope and the RNA-Dependant RNA Polymerase (RdRp) Coding Regions. Viruses. 2020 06 25; 12(6).
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.